| ||||||||||||||||||||
|
| 1 to 10 of 1262: |
|
|
|||||
| New Diagnostic Test Helping in the Fight Against Ovarian Cancer 20 Aug 2010: A new test for ovarian cancer was demonstrated to be 99% to 100% accurate over 100 patient samples by Researchers at Georgia Institute of Technology. This new diagnostic technique is able to test a single drop of blood serum using JEOL's AccuTOF™-DART® mass spectrometer. JEOL USA |
|||||
New Kits for Patients with Multiple Myeloma 19 Aug 2010: Binding Site has launched 4 more Hevylite™ kits. Hevylite is CE marked for use in monitoring patients with Multiple Myeloma and other B cell dyscrasias.The Binding Site Ltd |
|||||
| In Vivo Monitoring of Fluorescently Labeled Cancer Cells 18 Aug 2010: This application poster demonstrates that both bioluminescence and fluorescence can be used to measure primary tumor growth and metastasis in vivo. Tumor progressions were monitored non-invasively and in real time using an enclosed imaging system containing a cooled CCD camera. Caliper Life Sciences |
|||||
| Use of Antibodies In Small Animal Molecular Imaging 18 Aug 2010: In vivo imaging enables the natural course of a disease or experimental model to be monitored. This application note discusses the use of fluorescently labeled primary antibodies for looking at protein expression in vivo imaging. The use of antibodies allows researchers to quickly determine if the test antibody begins to target undesired organs such as the kidneys or livers. Carestream Molecular Imaging |
|||||
| Omega Optical Receive Award to Develop Multispectral Imaging for Cancer Research 11 Aug 2010: The phase II SBIR award from the National Cancer Institute has been given to Omega Optical to develop a high-speed fiber optic based optical spectrum analyzer (OSA) that will be interfaced to confocal scanning microscopy and endoscopy systems. This product research is looking to aid the detection and treatment of cancer. Omega Optical |
|||||
Randox Provides Improved Stroke and Heart Attack Patient Profiling 11 Aug 2010: Randox now offers Metabolic Syndrome Arrays for the simultaneous determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling. Individuals with Metabolic Syndrome are more likely to have a stroke, heart attack or develop type 2 diabetes.Randox Laboratories Ltd |
|||||
New Flow-Validated Antibodies for Detecting Phosphorylation of Intracellular Proteins in Whole Blood 09 Aug 2010: The Cell Lab Signaling Cytometry (Cell Lab SC) line of reagents from Beckman Coulter, Inc., offers a set of antibodies for the detection of the phosphorylation state of signaling proteins in cells via flow cytometry. Performing cell signaling experiments via flow enables the user to generate precise, specific and quantitative measurements of the signaling response in individual cellular subpopulations.Beckman Coulter |
|||||
New Single Use Test for the Microscopic Counting of Leukocytes and Platelets in Whole Blood 04 Aug 2010: LeukoChek is a new single use test for the microscopic counting of leukocytes and platelets in whole blood from Biomedical Polymers, Inc. It is designed to be the functional equivalent of the discontinued Unopette from Beckton, Dickinson and Company.Biomedical Polymers, Inc |
|||||
| Gosselin Opens Manufacturing Facility in Blackburn, UK 03 Aug 2010: One year ago, Gosselin made the decision to cross the English Channel in order to be closer to its northern European end users and business partners. East Lancashire was an ideal location for Gosselin to establish its UK manufacturing facility partly because of direct access to its UK customers and partly because of the availability of an experienced local workforce. Gosselin |
| To page |
